top of page

TECHNICAL LITERATURE

Note: Our patented MASC® technology stands for Mobile Affinity Sorbent Chromotography. In some of the resources below, the S was mistakenly labeled as "Selection." 

Application Notes 

​​

Proteometer-L
 

Analysis of Adalimumab With Novilytic's Proteometer-L Kit - December 2025

​

Proteometer-L Analysis of Tislelizumab​ - November 2025

​

Improved Method for Biosimilar Comparison of Aggregate Profile With Originator mAb - March 2025

Aggregate Content of NIST mAb RM 8671 by the Proteometer-L Kit - Comparison With NIST Values - March 2025

 

Proteometer-L Kit for Titer and Aggregate Analysis of mAbs Produced in HEK-293 Cells - March 2025

 

Quality Assessment of Aglycosylated Therapeutic Monoclonal Antibodies With Proteometer-L Kit - July 2024

​​

Application of Proteometer-L Kit in the Development of mAbs With Reduced FcϒR Effector Function - July 2024

​

Titer Accuracy Comparison of Bispecific Antibody (bsAb) Using MASC Versus Protein A Purification - May 2024

​

Analysis of Rituximab, an IgG1 subclass mAb, with Proteometer-L Assay - April 2024

​

Analysis of Denosumab, an IgG2 Subclass mAb, with Proteometer-L Assay - April 2024

​

Analysis of Nivolumab, an IgG4 Subclass mAb, with Proteometer-L Assay - April 2024

 

Introduction to the Proteometer-L Kit - November 2022​

​

Proteometer-CV

​

Analysis of Denosumab Biosimilar With Novilytic’s Proteometer-CV Kit - Nov. 25, 2025

​​

Analysis of Rituximab Biosimilar With Novilytic’s Proteometer-CV Kit - October 22, 2025

​

Analysis of NIST Monoclonal Antibody RM 8671 With Novilytic’s Proteometer-CV Kit - October 22, 2025

​

Proteometer-CV Charge Variant Profle - October 21, 2025

bottom of page